Targanta Therapeutics
Cambridge
About Targanta Therapeutics
Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $70.0M
- Funding stage: M&A
- Last round: Series C (Feb 2007)
- Ticker: nasdaq:TARG
- Website: targanta.com
- Phone: +1 973-290-6000
Industries & Categories
Biopharma, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/targanta-therapeutics-1697178 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.